0001179110-12-009809.txt : 20120608 0001179110-12-009809.hdr.sgml : 20120608 20120608154012 ACCESSION NUMBER: 0001179110-12-009809 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120607 FILED AS OF DATE: 20120608 DATE AS OF CHANGE: 20120608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MICHELSON JACK CENTRAL INDEX KEY: 0001236490 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13305 FILM NUMBER: 12897782 MAIL ADDRESS: STREET 1: 335 BASSWOOD DRIVE CITY: NORTHBROOK STATE: IL ZIP: 60062 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WATSON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884629 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953872914 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 9092701400 MAIL ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 edgar.xml FORM 4 - X0305 4 2012-06-07 0 0000884629 WATSON PHARMACEUTICALS INC WPI 0001236490 MICHELSON JACK 335 BASSWOOD DRIVE NORTHBROOK IL 60062 1 0 0 0 Common Stock, par value $0.0033 2012-06-07 4 M 0 10000 36.80 A 26064 D Common Stock, par value $0.0033 2012-06-07 4 S 0 10000 69.79 D 16064 D Common Stock, par value $0.0033 2012-06-07 4 S 0 10000 69.80 D 6064 D Non-Qualified Options to Purchase Common Stock 36.80 2012-06-07 4 M 0 10000 0 D 2006-05-19 2013-05-19 Common Stock, par value $0.0033 10000 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.61to $70.36, inclusive. The reporting person undertakes to provide to Watson Pharmaceuticals, Inc., any security holder of Watson Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.63 to $70.35, inclusive. The reporting person undertakes to provide to Watson Pharmaceuticals, Inc., any security holder of Watson Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc. /s/JACK MICHELSON 2012-06-08